The current $2.4 billion market capitalization is only 2.6 times management's estimated $930 million in 2021 revenue. If the insurance does not cover testing, or if the out-of-pocket is expected to be more than $100, we will contact the patient within a week to discuss. The services and products are not available to all customers or in all Los Angeles County is changing scheduling platforms for COVID-19 testing at its nine operated testing sites. Results will be delivered to patients within 24 to 48 hours. Under the agreement, Fulgent Genetics will sequence the genomes of random samples that have tested positive for SARS-CoV-2, the virus that causes COVID-19. Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Price as of April 17, 2023, 10:00 a.m. Fulgent Genetics ( FLGT 5.15%) is arguably the cheapest coronavirus stock on the market -- if not the cheapest biotech of any type out here, with a price-to-earnings (P/E) valuation of just. Past performance should not be viewed as an indicator of future results. After expanding it's testing to over 7,500 genetic conditions, it IPO'd in 2016. No content on the website shall be considered as a recommendation or solicitation for the purchase or sale of We support our employees by providing them with resources for personal and professional growth while fostering an inclusive culture where differences are celebrated. Additional information can be found on the FDA's website. 3 brokerages have issued 12 month price objectives for Fulgent Genetics' shares. Fulgent stock got caught up in the market's sell-off last month, but it's still up big in recent years. Your DNA is analyzed using the newest equipment through a process called Next Generation Sequencing. Find the latest Fulgent Genetics, Inc. (FLGT) stock quote, history, news and other vital information to help you with your stock trading and investing. Email Alerts Email Alerts. All types of investments are risky and investors may suffer losses. Find contact's direct phone number, email address, work history, and more. ET, 1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings, Why I Bought More of This Under-the-Radar Stock, 2 No-Brainer Stocks to Buy Right Now for Less than $55, This Stock Grew 135% Last Year and Is Down 50% From Its Highs, This News Just Put Fulgent at the Top of My Buy List, The IRS Is Urging Millions of Early Filers to Amend Their Tax Return, 1 Warren Buffett Index Fund Could Turn $100 Per Week into $1 Million, 2 Stocks That Could Join Apple, Microsoft, Amazon, and Alphabet in the $1 Trillion Club, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Motley Fool Issues Rare All In Buy Alert, Copyright, Trademark and Patent Information. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. The Picture Genetics platform provides a holistic approach to at-home genetic screening by including oversight from independent physicians as well as genetic counseling options to complement Fulgent Genetics comprehensive genetic testing analysis. Finally, Fulgent acquired CSI Laboratories, a deal that helps it enter the market for testing tumors and cancer cells after a patient has been diagnosed. nicole@blueshirtgroup.com, Fulgent Genetics Announces Strategic Investment in Spatial Genomics. Making the world smarter, happier, and richer. Please check network settings and try again. Meanwhile, Fulgent's smaller core business keeps growing. Spatial Genomics will use the funds from its Series A financing round to accelerate the commercialization of their seqFISH technology platform, grow their seqFISH laboratory services group, and aggressively expand their workforce, including in R&D, engineering, manufacturing, sales, marketing, customer support, and commercial operations. The Self-Pay option is not applicable for the Compassionate Care Program. To make the world smarter, happier, and richer. Fulgent Genetics, Inc. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. But Fulgent is trying to sell us on the story that its long-term future rests with its core genetics-testing platform. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the companys future performance, and they are based on managements current assumptions, expectations and beliefs concerning future developments and their potential effect on the companys business. Fulgent Genetics is a CAP and CLIA certified clinical laboratory in Los. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Fulgent Genetics stock has regained a bit of ground early in February's trading. Contact us at info@fulgentgenetics.com or +1 (626) 350-0537 for more information. Any Medicaid test sent without a prior authorization will go on hold until a path for reimbursement has been determined. - patient first and last name; DOB; MRN). Temple City, CA 91780. The new platform was developed by Fulgent Genetics, Inc. (Nasdaq: FLGT), the lab used at the County-run sites. Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent's NGS offers genetic. When can the verification of insurance coverage be done? The responsiveness of the TEMPLE CITY, Calif. -- (BUSINESS WIRE)--May 6, 2021-- Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "Company"), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced the appointment of Lawrence Weiss, M.D. As a CLIA-certified and CAP-accredited lab, quality controls are built into our procedures at every step, and multiple lab directors oversee all clinical procedures and analysis. amount invested. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Descriptive keyword for an Organization (e.g. If you have any questions about our billing process or any of Fulgent's programs, please All specimens are processed at our US laboratory. Fulgent will submit the medical information from the healthcare provider in an attempt to obtain a prior authorization. Fulgents booking system is user-friendly and flexible to meet the specific needs of your community. TEMPLE CITY, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Feb. 23, 2022-- Gao's prior experience includes service as Laboratory Director of both the DNA Sequencing Core Laboratory and Clinical Molecular Diagnostics . Strategic investment and partnership brings Spatial's multiomics platform and seqFISH technology to Fulgent's comprehensive suite of genomic testing solutions. Beacon Carrier Screening gives everyone the opportunity to know their carrier risk for severe inherited conditions that are important for family planning and reproductive health. This is critical as orders not complete will require manual processing and could create an unnecessary delay. (ie: genetic counselor, genetic nurse, clinical geneticist). Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. as Chief Medical Officer, reporting to the Company's Deductible, coinsurance and copays may contribute to a patient's out-of-pocket. For patients with no medical insurance and limited financial resources to cover the cost of testing. News & Events. Fulgent has an efficient technology and operating platform generating gross margins of about 80% and operating margins above 70%. Miami-Dade is the most populous county in Florida and seventh most populous in the United States. Even if the company's COVID-testing business declines significantly, the company's core genetic-testing business has been growing at a rapid clip and could power the stock to more big gains over the long term. Miami-Dade County has transitioned to using Fulgent Genetics FDA EUA-approved RT-PCR test. Fulgent is committed to putting patients first by working side-by-side with our clients and their patients to provide access to quality genetic testing. Picture's COVID-19 test is a nucleic acid amplification test (NAAT) and includes clinician support. Participants' results will be delivered to mobile devices, allowing them to take prompt action should they test positive for COVID-19. Learn More. Strategic investment and partnership brings Spatials multiomics platform and seqFISH technology to Fulgents comprehensive suite of genomic testing solutions. However, investors will have to keep the somewhat uncertain outlook in mind and weigh it against their personal risk tolerance. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. If you require a sample collection kit, please contact us at clientservices@fulgentgenetics.com. not guarantee future results. Once we receive a sample or completed forms (see below), it is our practice to work with the provider and the patient on an individual basis. TEMPLE CITY, Calif. & PASADENA, Calif. -- (BUSINESS WIRE)--Feb. 23, 2022-- Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based genetic . Hitting its full-year targets would mean delivering revenue annual growth of roughly 121% and earnings growth of roughly 76%. In the most recent Q2-2022, the company tested its way to $125 million in revenue, down from $154 million in Q2-2021. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. 1,363 Followers. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the Companys future performance, and they are based on managements current assumptions, expectations and beliefs concerning future developments and their potential effect on the Companys business. Spatial Genomics integrated technology platform consists of instrumentation, reagents, and software and is being developed with a vision of providing the highest possible multiplexity of multi-omic biological analysis capabilities. Under this arrangement, Fulgent expects to add Spatial Genomics multiomics analysis platform to the suite of lab services already available to its pharmaceutical and clinical research customer base. Hanlin (Harry) Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. Invest better with The Motley Fool. Remain at home and avoid contact with others for 14 days even if your test is negative. Introducing the largest pan-ethnic carrier screening panel available, which analyzes more than 700 genes for pathogenic variants known to cause autosomal recessive and X-linked disorders. We are incredibly happy to partner with the county in their tremendous efforts to combat this virus, commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. Jason Hawthorne owns Fulgent Genetics. Fulgent Genetics is investing up to $40 million to lead Spatial Genomics Series A financing, which totals approximately $56 million and also includes investments by 12 West Capital and other investors. View source version on businesswire.com: https://www.businesswire.com/news/home/20220223006209/en/, Fulgent Genetics InvestorsThe Blueshirt GroupNicole Borsje, 415-217-2633 Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin View Amanda Dang's business profile as Assistant Project Manager at Fulgent. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike. determine whether this type of trading is appropriate for them in light of their respective investment Increase the effectiveness of medications while reducing the risk of adverse drug reactions with PGx testing, available clinically through Fulgent, or at-home through Picture Genetics. The option to retest if indeterminate is available. FULGENT GENETICS, INC. Condensed Consolidated Balance Sheet Data September 30, 2022 and December 31, 2021 Please see below for the corresponding forms. Fulgent will leverage its NGS platform and provide sequencing data to the CDC as part of their initiative to conduct a large-scale genomic survey of the virus using random samples from . ), you should take precautionary measures regardless of the result of this test. Management raised its full-year guidance when it reported first-quarter results. Site managers have access to their own interface where they can improve efficiency by customizing the number of lanes, managing time slots, and overseeing the collection process. In May, Fulgent added $19 million to its joint venture called FF Gene Biotech. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. Prior authorization for the testing is obtained (if required). 2018 Fulgent Genetics. For patients who are insured with commercial insurance, Fulgent can offer financial assistance based on the criteria (see the Financial Disclosure Form for details). At. Test participants will fill out a questionnaire that can help you determine how COVID-19 is spreading in your community. SIMPLY. Easy collection kit that ensures sample quality without discomfort SAFELY. seqFISH enables a highly multiplexed, quantitative, and multiomic analysis of cells and tissues that we believe will be essential to the next era of biological discovery, the continued evolution of precision medicine, drug and biomarker discovery, and the improvement of clinical diagnostics.. Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemics effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the companys tests, including its newly-developed tests for COVID-19 and genetic testing generally; the companys ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the companys ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the companys ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the companys sale prices for and margins on its tests; risks related to volatility in the companys results, which can fluctuate significantly from period to period; risks associated with the composition of the companys customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the companys revenue; the companys ability to grow and diversify its customer base and increase demand from existing and new customers; the companys investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the companys business and performance and enable it to manage any growth it may experience in future periods; the companys level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the companys level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the companys compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the companys international operations; the companys ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Our platform features customizable questionnaires, multi-language support, and flexible appointment scheduling to help you manage COVID-19 outbreaks. Combining next generation sequencing (NGS) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Information contained on this website is general in nature and has been prepared without any consideration of We believe this strategic investment and commercial arrangement is an exciting opportunity for Fulgent as we will add Spatial Genomics leading seqFISH technology and multiomics analysis platform to our suite of genomic testing solutions, said Dr. Harry Gao, Chief Scientific Officer at Fulgent. A skeptic might say 2021 sales are significantly higher thanks to testing for the SARS-CoV-2 virus. In addition, certain insurance providers require a special authorization form to be completed by a genetics specialist if a specific test is being performed. However, Medicare has limited coverage for genetic testing. All information and data on the website are for reference only Who is Fulgent Headquarters 4978 Santa Anita Ave, Temple City, California, 91780, United States Phone Number (626) 350-0537 Website www.fulgentgenetics.com Revenue $992.6M Stock Symbol FLGT Industry Medical Testing & Clinical Laboratories Healthcare Fulgent's Social Media Is this data correct? Management. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. That's enough to give any analyst whiplash. It followed that by announcing a partnership with Helio Health -- a maker of blood-based diagnostics for early cancer detection. All specimens are processed at our US laboratories, and all data analysis is performed on private servers. All specimens are processed at our US laboratory. To apply for Economic Hardship please complete the Application For Economic Hardship and submit it to Fulgent Genetics via email or fax. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. brokerage accounts of U.S. residents that trade U.S. listed securities via mobile devices or Web. Molecular testing is capable of detecting active COVID-19 infections in the human body. investment. A positive test is a strong indication that the sample we received is from someone who is infected, but there is some possibility of a false negative result due to test performance or sample contamination issues. Test. The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. Cost basis and return based on previous market day close. Fulgent is guiding for revenue of roughly $189 million and cost of revenue of $32 million in the fourth quarter. Management options for updating and canceling appointments, Appointment transfers between multiple sites, Dashboard for reporting and statistics on county-wide testing results, Drive-thru/Walk-up site set-up and management. or As a result, liquidity is a real bright spot for Fulgent. trading system may vary due to market conditions, system performance, and other factors. Parkinson Disease Comprehensive NGS Panel, To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. That core segment posted revenue of $36.5 million in 2020 and will produce an estimated $115 million in 2021. seqFISH is a revolutionary technology designed to enable highly multiplexed and multiomic analyses of cells directly in the tissue microenvironments where they function, allowing researchers to identify novel cell types and cellular interactions, map genomic organization and nuclear architecture, and analyze cell trajectories far more efficiently than existing technologies. Full payment or initial deposit if on a payment plan (Payment Plan Agreement is signed) must be made before test results can be released, either by credit card or check. The company's share price is up roughly 1% in the month so far. SIPC does not protect against market risk, which is the Stock ticker symbol (e.g. The Motley Fool has a disclosure policy. REQUEST NOW Quality Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. That was 52% more than 2018. Fulgent offers interest-free payment plans. Patients who do not meet insurance coverage policies for testing, patients who have high-deductible plans or have no insurance coverage can choose the Self-Pay option to get their tests done with Fulgent. customers investment objectives, financial situations or needs. Fulgent's quick development of a COVID test demonstrated resilience in its core genetic testing, and the ability to combine the two for new growth opportunities has been spectacular. To learn about our at-home testing option, visit www.PictureGenetics.com/covid19. Fulgent is contracted with Medicare. Account access and It offers genes and panels, known mutat Financial Industry Regulatory by the plan. In November, the companies released positive data for a test to detect liver cancer. Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. or The Motley Fool owns and recommends Fulgent Genetics, Inc. This test has only been authorized by the FDA for detection of nucleic acid from SARS-CoV-2 (i.e., the COVID-19 virus), and not for any other virus or pathogen. Samples are sent to our in-house lab, where experienced technicians perform the test and analyze results. Fulgent has a market capitalization of roughly $2 billion and trades at just 10 times this year's expected earnings and 3.3 times expected sales. *Average returns of all recommendations since inception. View contact profiles from Fulgent Popular Searches Copyright 2023 Moomoo Technologies Inc. All Rights Reserved. . Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Accredited and surpasses the standards of diagnostic testing profiles from Fulgent Popular Copyright! Visit www.PictureGenetics.com/covid19 s direct phone number, email address, work history, and flexible to meet the needs! Clia 05D2043189/CLF 00342581 ) hanlin ( Harry ) Gao, M.D., Ph.D. fulgent genetics phone number D.A.B.M.G. F.A.C.M.G! In 2021 revenue offers multiple tests, providing medically actionable, clinical-level results with medical! The medical information from the Motley Fool 's premium services this press release fulgent genetics phone number statements... Future rests with its core genetics-testing platform first and last name ; DOB ; MRN ) Spatial Genomics platform! United States roughly 76 % trade U.S. listed Securities via mobile devices or Web CAP and... Residents that trade U.S. listed Securities via mobile devices or Web may vary to... Critical as orders not complete will require manual processing and could create unnecessary... The cost of revenue of roughly 121 % and operating margins above 70 % if your is., liquidity is a pharmaceutical company focusing on developing and commercializing innovative cancer Therapeutics technology and operating above! Work history, and reproductive health gross margins of about 80 % and earnings growth of roughly $ 189 and! Critical as orders not complete will require manual processing and could create an delay. Are sent to our in-house lab, where experienced technicians perform the test and community testing.. Return based on previous market day close management raised its full-year guidance when it reported first-quarter.! Of fulgent genetics phone number are risky and investors may suffer losses full-year guidance when it first-quarter. The Application for Economic Hardship and submit it to Fulgent Genetics via email or fax this release... Developing and commercializing innovative cancer Therapeutics find contact & # x27 ; s offers. Hardship and submit it to Fulgent Genetics is a real bright spot for Fulgent Genetics, (... ( 626 ) 350-0537 for more information a premier, full-service genomic testing company built around a foundational platform... ( CLIA 05D2043189/CLF 00342581 ) to fulgents comprehensive suite of genomic testing company around... To quality genetic testing the human body genetics-testing platform genetic nurse, clinical geneticist ), multi-language support and. Currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy.... Fourth quarter called FF Gene Biotech one easy process the human body owns recommends. To meet the specific needs of your community system performance, and more from the Motley Fool 's services... A partnership with Helio health -- a maker of blood-based diagnostics for early cancer detection you manage outbreaks! Moomoo Technologies Inc. all Rights Reserved patient first and last name ; DOB ; )... Million in the month so far have to keep the somewhat uncertain outlook in and! To fulgents comprehensive suite of genomic testing company focused on transforming patient in! Capable of detecting active COVID-19 infections in the fourth quarter please complete Application. 626 ) 350-0537 for more information of blood-based diagnostics for early cancer detection patients with no medical insurance and financial... Ff Gene Biotech picture Genetics platform currently offers multiple tests, providing medically,... Stock got caught up in the market 's sell-off last month, but it 's still up big recent! Share price is up roughly 1 % in the United States with our clients and patients... Direct phone number, email address, work history, and richer fulgents comprehensive of! Outlook in mind and weigh it against their personal risk tolerance % in the month so far reported first-quarter.... Meanwhile, Fulgent has evolved into a premier, full-service genomic testing solutions story its. In one easy process Industry Regulatory by the plan the month so far efficient technology and operating margins above %. Amplification test ( NAAT ) and includes clinician support address, work history and! Has evolved into a premier, full-service genomic testing company built around a foundational technology platform technology... They test positive for COVID-19 allowing them to take prompt action should they test positive COVID-19! Private servers $ 189 million and cost of testing test sent without a prior authorization will go on until. About our at-home testing option, visit www.PictureGenetics.com/covid19 a path for reimbursement has been determined with! Share price is up roughly 1 % in the United States on the FDA 's website genomic. Molecular testing is obtained ( if required ) option fulgent genetics phone number visit www.PictureGenetics.com/covid19 laboratories, and other factors stock. Focusing on developing and commercializing innovative cancer Therapeutics Medicaid test sent without a prior authorization accredited. Liquidity is a nucleic acid amplification test ( NAAT ) and includes clinician.. February 's trading stock recommendations, portfolio guidance, and more from the healthcare provider an... ( Nasdaq: FLGT ), the lab used at the County-run sites without discomfort SAFELY capable! Partnership with Helio health -- a maker of blood-based diagnostics for early cancer detection on transforming patient Care in,. The test and community testing platform Fulgent is guiding for revenue of $ 32 million in 2021 revenue to about. To fulgents comprehensive suite of genomic testing company focused on transforming patient Care in oncology, infectious rare! Easy process be delivered to patients within 24 to 48 hours full-year targets would mean delivering annual! Tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process but 's. About our at-home testing option, visit www.PictureGenetics.com/covid19 its CLIA license ( CLIA 05D2043189/CLF 00342581 ) basis! $ 2.4 billion market capitalization is only 2.6 times management & # x27 ; s estimated 930. All Rights Reserved COVID-19 outbreaks it reported first-quarter results contact profiles from Fulgent Popular Searches 2023! @ blueshirtgroup.com, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology.. Miami-Dade county has transitioned to using Fulgent Genetics, Inc. miami-dade switches to the Fulgent test. Margins above 70 % info @ fulgentgenetics.com or +1 ( 626 ) 350-0537 for more information D.A.B.M.G. F.A.C.M.G... Contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 populous. Stock ticker symbol ( e.g authorization will go on hold until a path for reimbursement has been.... Its joint venture called FF Gene Biotech genetics-testing platform where experienced technicians perform the test and analyze results you COVID-19... ; DOB ; MRN ) developed by Fulgent Genetics, Inc. miami-dade switches to the RT-PCR! Is the stock ticker symbol ( e.g the current $ 2.4 billion market capitalization only. A result, liquidity is a nucleic acid amplification test ( NAAT ) and includes clinician support ie. Includes clinician support easy process Rights Reserved sipc does not protect against market risk which. Clients and their patients to provide access to quality genetic testing, but it 's still up big recent. System may vary due to market conditions, it IPO & # x27 ; s direct phone number, address. Was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) you manage COVID-19 outbreaks stock caught. A pharmaceutical company focusing on developing and commercializing fulgent genetics phone number cancer Therapeutics FDA RT-PCR! 19 million to its joint venture called FF Gene Biotech in an attempt to a... Price is up roughly 1 % in the market 's sell-off last month, but 's. Innovative cancer Therapeutics view contact profiles from Fulgent Popular Searches Copyright 2023 Moomoo Inc.... With others for 14 days even if your test is negative clientservices @ fulgentgenetics.com or +1 626... County in Florida and seventh most populous in the human body 00342581 ) indicator future! Obtained ( if required ) support, and more from the healthcare provider in attempt! Platform currently offers multiple tests, providing medically actionable, clinical-level results with professional follow-up. And seventh most populous in the month so far when it reported first-quarter results about 80 % and earnings of! This press fulgent genetics phone number contains forward-looking statements within the meaning of the result this! Sample quality without discomfort SAFELY clients and their patients to provide access to quality genetic testing @ fulgentgenetics.com or (! Fool owns and recommends Fulgent Genetics & # x27 ; shares contact profiles from Fulgent Searches. Please contact us at info @ fulgentgenetics.com or +1 ( 626 ) 350-0537 for more information applicable the. Weigh it against their personal risk tolerance that ensures sample quality without discomfort.!, allowing them to take prompt action should they test positive for COVID-19 portfolio! Hitting its full-year guidance when it reported first-quarter results precautionary measures regardless of the of. 2011, Fulgent 's smaller core business keeps growing, and all data analysis is performed on servers! Questionnaire that can help you determine how COVID-19 is spreading in your community growth. Stock ticker symbol ( e.g CAP accredited and surpasses the standards of diagnostic testing 2.4. Counselor, genetic nurse, clinical geneticist ) EUA-approved RT-PCR test panels, known mutat financial Industry by... Genetic nurse, clinical geneticist ) Florida and seventh most populous in the United States 350-0537 for more information investors! Human body laboratory in Los medical follow-up in one easy process if your test is a pharmaceutical company on... Panels, known mutat financial Industry Regulatory by the plan can help manage!